首页> 美国卫生研究院文献>Journal of Cancer >The Novel Prognostic Score Combining Red Blood Cell Distribution Width and Body Mass Index (COR-BMI) Has Prognostic Impact for Survival Outcomes in Nasopharyngeal Carcinoma
【2h】

The Novel Prognostic Score Combining Red Blood Cell Distribution Width and Body Mass Index (COR-BMI) Has Prognostic Impact for Survival Outcomes in Nasopharyngeal Carcinoma

机译:结合红细胞分布宽度和体重指数(COR-BMI)的新型预后评分对鼻咽癌的生存结局具有预后影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: A novel inflammation-and nutrition-based scoring system based on red blood cell distribution width and body mass index (COR-BMI) has prognostic value in nasopharyngeal carcinoma (NPC). Here, we assessed the prognostic value of COR-BMI in NPC.>Methods: Retrospective study of 2,318 patients with non-metastatic NPC treated at Sun Yat-sen University Cancer Center was conducted. Patients were stratified into three groups using the COR-BMI score, which is based on two objective and easily measurable parameters: red blood cell distribution width (RDW) and body mass index (BMI). Kaplan-Meier survival analyses were used to compare groups; multivariate Cox proportional models were used to calculate overall survival (OS) and disease-free survival (DFS).>Results: Four-year overall survival (OS) rates were 88.7%, 84.5%, and 71.4% for patients with COR-BMI scores of 0, 1, and 2 respectively (P = 0.006). Multivariate Cox proportional hazard analysis revealed COR-BMI was an independent predictor of OS (HR for COR-BMI 1: 1.239, 95% CI: 1.012-1.590; HR for COR-BMI 2: 2.367, 95% CI: 1.311-4.274, P = 0.013), but not DFS (P = 0.482). In subgroup analysis of metastatic NPC, OS rates decreased as COR-BMI increased. In patients with a COR-BMI score of 1, radiotherapy plus chemotherapy led to better OS than radiotherapy alone.>Conclusions: COR-BMI may serve as an indicator of poor prognosis in both NPC and metastatic NPC. Radiotherapy plus chemotherapy may benefit patients with a COR-BMI score of 1.
机译:>背景:一种基于炎症和营养的新型评分系统,该系统基于红细胞分布宽度和体重指数(COR-BMI)对鼻咽癌(NPC)具有预后价值。在这里,我们评估了COR-BMI在NPC中的预后价值。>方法:在中山大学癌症中心对2318例非转移性NPC患者进行了回顾性研究。使用COR-BMI评分将患者分为三组,该评分基于两个客观且易于测量的参数:红细胞分布宽度(RDW)和体重指数(BMI)。 Kaplan-Meier生存分析用于比较各组。多变量Cox比例模型用于计算总生存期(OS)和无病生存期(DFS)。>结果:四年总生存率(OS)分别为88.7%,84.5%和71.4% COR-BMI评分分别为0、1和2的患者(P = 0.006)。多变量Cox比例风险分析显示COR-BMI是OS的独立预测因子(COR-BMI的HR 1:1.239,95%CI:1.012-1.590; COR-BMI的HR 2:2.367,95%CI:1.311-4.274, P = 0.013),但不是DFS(P = 0.482)。在转移性NPC的亚组分析中,OS率随着COR-BMI的增加而降低。在COR-BMI评分为1的患者中,放疗加化疗比单独放疗具有更好的OS。>结论: COR-BMI可以作为NPC和转移性NPC不良预后的指标。放疗加化疗可能会使COR-BMI评分为1的患者受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号